Skip to content

Clinical trials

Phase 2 Osteoporosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Phase: Phase 2 Clear all

133 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20021
20033
20048
20057
20066
20078
200812
20098
20103
20116
20126
20134
20145
20156
20162
20173
20185
20192
20204
20212
20221
20231
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed99
Unknown status11
Terminated10
Withdrawn5
Recruiting4
Active, not recruiting2
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital7
Amgen5
Eli Lilly and Company4
Merck Sharp & Dohme LLC4
National Center for Complementary and Integrative Health (NCCIH)4
Northwestern University4
Shinshu University4
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
Children's Hospital of Eastern Ontario2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis133
Bone Diseases, Metabolic34
Osteoporosis, Postmenopausal13
Bone Diseases9
Spinal Cord Injuries8
Fractures, Bone7
Musculoskeletal Diseases6
Anorexia Nervosa4
Spinal Cord Diseases4
Bone Resorption3

Trials

Showing 51 to 75 of 133. Each trial links to its page on Pharma Observatory.

33 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.